Morning Brew Daily
X’s Location Feature Stirs Uproar & Novo Nordisk Tanks After Failed Alzheimer’s Trial
This episode isn’t summarized yet
Create a free account and summarize it. In a few minutes you’ll have the key takeaways and a section-by-section summary.
Show notes
Episode 721: Neal and Toby chat about X’s new location transparency feature that has opened up a can of worms as some of the most divisive accounts on US politics aren’t actually from the US. Then, Novo Nordisk has taken a big hit after its trials to develop a drug to delay Alzheimer’s have failed. Plus, the Trump administration makes access to federal student loans stricter, particularly for nurses. Meanwhile, is cigarette smoking cool again?
Learn more at usbank.com/splitcard
Get your MBD live show tickets here! https://www.tinyurl.com/MBD-HOLIDAY
Subscribe to Morning Brew Daily for more of the news you need to start your day. Share the show with a friend, and leave us a review on your favorite podcast app.
Listen to Morning Brew Daily Here: https://www.swap.fm/l/mbd-note
Watch Morning Brew Daily Here: https://www.youtube.com/@MorningBrewDailyShow
Learn more about your ad choices. Visit megaphone.fm/adchoices